BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Everest Medicines Announces Participation in September 2025 Investor Conferences

  August 26, 2025

   · 

  1 min read
• Press Releases

  FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics

  August 26, 2025

   · 

  3 min read
• Press Releases

  Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

  August 26, 2025

   · 

  5 min read
• Press Releases

  Scribe Therapeutics to Demonstrate Scientific and Corporate Leadership at Upcoming Conferences

  August 26, 2025

   · 

  2 min read
• Press Releases

  LivaNova to Host Investor Day on November 12, 2025

  August 26, 2025

   · 

  2 min read
• Press Releases

  Bio-Rad’s Management to Participate in Upcoming September 2025 Investor Conferences

  August 26, 2025

   · 

  1 min read
• Press Releases

  Immix Biopharma to Present at the Stifel 2025 Healthcare Conference

  August 26, 2025

   · 

  3 min read
• Press Releases

  Baylor Genetics to Showcase RNA Sequencing Breakthroughs for Rare Disease Diagnosis at 2025 AGBT Precision Health Meeting

  August 26, 2025

   · 

  2 min read
• Press Releases

  Actuate Therapeutics Advances a New Era in Oncology with Potential Universal Backbone Therapy

  August 26, 2025

   · 

  10 min read
• Press Releases

  Clongen Laboratories, LLC Announces Launch of Sister Company Clongen Pharma, LLC in March 2026

  August 26, 2025

   · 

  2 min read